Protalix BioTherapeutics (PLX) Earnings Date & Reports

Industry: @Servicestothe Health Industry

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 300.00% to 5 cents per share on November 06

Protalix BioTherapeutics PLX Stock Earnings Reports

Q3'24

Est.

$0.06

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.04

Q4'23

Est.

$-0.03

Q3'23

Est.

$-0.04

The last earnings report on August 14 showed earnings per share of -2 cents, missing the estimate of 1 cents. With 239.08K shares outstanding, the current market capitalization sits at 77.22M.

View a ticker or compare two or three

Compare

PLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PLX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Servicestothe Health Industry

Address

2 University Plaza

Phone

+1 201 696-9345

Employees

208

Web

https://www.protalix.com